Dispatched Within 24 Hours
Referenced in Human Studies
Third-Party COA Verified
Sourced from Trusted Labs in EU
Scientific Advisory Oversight
CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.
Our local team are here to help
Have more questions about peptide research? You’re not alone. Explore our Frequently Asked Questions for quick answers—or head to the Knowledge Base to explore study areas, calculators, and protocol guides.
CJC-1295 with DAC is frequently studied for its long-acting support of growth hormone levels in extended research protocols.
The DAC (Drug Affinity Complex) allows the peptide to stay active in the body for a longer period.
It’s often used in weekly or biweekly protocols due to its extended half-life.
Yes, it’s frequently paired with Ipamorelin or other secretagogues for GH axis studies.
Refrigerate after reconstitution and use within 30 days.